Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)

Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, Massimo Santoro, Neil Q. Mcdonald, Fengping Lv, Naresh Gunaganti, Brendan Frett, Hong Yu Li

Research output: Contribution to journalComment/debatepeer-review

Abstract

Page 1733. In Table 1, all citations of ref 108 should be replaced with a new reference SEER data. http://seer.cancer. gov.

Original languageEnglish (US)
Pages (from-to)10089
Number of pages1
JournalJournal of Medicinal Chemistry
Volume63
Issue number17
DOIs
StatePublished - Sep 10 2020

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'Correction: Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application (Journal of Medical Chemistry (2019) 62:4 (1731−1760) DOI: 10.1021/acs.jmedchem.8b01092)'. Together they form a unique fingerprint.

Cite this